Pulmicort Aerosol, Powder
Product Images NDC 85612-010

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Pulmicort (NDC 85612-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rubicon Holdings Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (180mcg Label)

Label for Pulmicort Flexhaler 180 mcg, a budesonide inhalation powder for oral inhalation. The label indicates 120 metered doses per inhaler and highlights prescription use (Rx only). It is distributed by Allegis Pharmaceuticals for Rubicon Holdings Inc. and licensed by CHEPLAPHARM Arzneimittel GmbH. Storage and usage instructions are included, along with a barcode.*

FDA Label Image

Image Description (90mcg Label)

The image shows the packaging label for Pulmicort Flexhaler 90 mcg (budesonide inhalation powder) by Rubicon Holdings Inc. It is an aerosol powder for oral inhalation with 60 metered doses per unit. The label includes dosage strength, usage instructions, and distributor information.*

FDA Label Image

Image Description (Image 01a)

Chemical structure of Budesonide, the active ingredient in PULMICORT FLEXHALER. The diagram shows the steroid backbone with functional groups including hydroxyls, carbonyl, and an acetal side chain.*

FDA Label Image

Image Description (Image 02a)

A line graph comparing the change in FEV1 (L) over 12 weeks among three groups: PULMICORT FLEXHALER 180 mcg (2 inhalations twice daily), PULMICORT TURBUHALER 200 mcg (2 inhalations twice daily), and placebo. The x-axis represents time in weeks, and the y-axis represents change in FEV1 in liters. The graph shows increases in FEV1 for both active treatments compared to placebo, with data points and sample sizes shown below the x-axis.*

FDA Label Image

Image Description (Image 03a)

A line graph showing the percent change in predicted FEV1 over a 12-week treatment period comparing PULMICORT FLEXHALER 90 mcg (4 inhalations twice daily), PULMICORT TURBUHALER 200 mcg (2 inhalations twice daily), and placebo. The graph plots average weekly changes with markers for each treatment group, indicating differences in lung function improvement over time.*

FDA Label Image

Image Description (Image 04a)

An instructional diagram showing parts of the Pulmicort Flexhaler, including the mouthpiece at the top, the dose indicator in the middle, and the brown grip at the bottom, alongside the inhaler's cover.*

FDA Label Image

Image Description (Image 05a)

An instructional illustration showing a hand holding a PULMICORT FLEXHALER inhaler device and preparing it for use. The image demonstrates the handling of the aerosol powder inhaler for respiratory administration of budesonide.*

FDA Label Image

Image Description (Image 06a)

An instructional illustration showing a hand twisting the base of a Pulmicort Flexhaler inhaler device. The image demonstrates the twisting action needed to prepare the inhaler for use.*

FDA Label Image

Image Description (Image 07a)

An instructional illustration showing a hand holding a Pulmicort Flexhaler inhaler, with a second hand turning the base, accompanied by the word 'Click' below, indicating the action needed to prepare the inhaler for use.*

FDA Label Image

Image Description (Image 08a)

An instructional diagram showing how to use the Pulmicort Flexhaler inhaler. It depicts a person holding the inhaler near their mouth, preparing to inhale the aerosol powder medication for respiratory inhalation.*

FDA Label Image

Image Description (Image 09a)

An illustration showing a close-up of a Pulmicort Flexhaler dose counter with numbers 100 and 120 visible, indicating the inhaler dose count. The image depicts part of the device used for respiratory inhalation aerosol powder delivery.*

FDA Label Image

Image Description (Image 10a)

An illustration showing a close-up view of the dose counter on a Pulmicort Flexhaler inhaler device, with the counter displaying the number 20. The image highlights the expiration indicator window on the inhaler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.